This is the classic website, which will be retired eventually. Please visit the modernized instead.
Working… Menu

Open-Label Rollover Study for Continuing Valbenazine Administration for the Treatment of Chorea Associated With Huntington Disease

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT04400331
Recruitment Status : Active, not recruiting
First Posted : May 22, 2020
Last Update Posted : November 2, 2023
Huntington Study Group
Information provided by (Responsible Party):
Neurocrine Biosciences

No Study Results Posted on for this Study
Recruitment Status : Active, not recruiting
Estimated Primary Completion Date : December 2023
Estimated Study Completion Date : December 2023